Is Acutus Medical, Inc. (AFIB) a Buy, Sell, or Hold?
OTC : AFIB
Acutus Medical, Inc. — Institutional Ownership
$0.0001 USD
$0.0 (9900.0%)
- Volume
- 96.27K
- Average Volume
- 3.92K
- Market Capitalization
- $2.99K
- P/E Ratio
- 0.00
- Dividend Yield
- 0.00%
- Price Target
- $1.50
- Year High
- $0.01
- Year Low
- $0.00
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $2.06
Institutional Ownership Summary
Institutional Ownership %
%
Investors Holding
change: 0.0 | last:
Increased Positions
change: 0.0 | last:
Reduced Positions
change: 0.0 | last:
New Positions
change: 0.0 | last:
Sold Positions
change: 0.0 | last:
Total Calls
-
Total Puts
-
Put-Call Ratio
change: 0.0 | last:
Total Invested
-
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-02-17 | Advent Life Sciences LLP | - | 0.00% |
| 2025-01-28 | Deerfield Partners, L.P. | 1.97M | 4.90% |
| 2025-01-28 | Deerfield Management Company, L.P. | 5.49M | 9.10% |
| 2025-01-28 | James E. Flynn | 5.49M | 9.10% |
| 2025-01-28 | Deerfield Mgmt, L.P. | 1.97M | 4.90% |
| 2025-01-28 | Deerfield Mgmt III, L.P. | 3.44M | 5.42% |
| 2025-01-28 | Deerfield Private Design Fund III, L.P. | 3.44M | 5.42% |
| 2025-01-23 | Deerfield Mgmt III, L.P. | 5.73M | 5.54% |
| 2025-01-23 | Deerfield Private Design Fund III, L.P. | 5.73M | 5.54% |
| 2025-01-23 | Deerfield Mgmt, L.P. | 3.9M | 4.90% |
| 2025-01-23 | Deerfield Partners, L.P. | 3.9M | 4.90% |
| 2025-01-23 | Deerfield Management Company, L.P. | 9.71M | 9.10% |
| 2025-01-23 | James E. Flynn | 9.71M | 9.10% |
| 2024-05-17 | Laurence W. Lytton | 1.75M | 11.00% |
| 2024-05-17 | Laurence W. Lytton | 1.75M | 11.00% |
| 2022-07-05 | Deerfield Private Design Fund III, L.P. | 5.73M | 5.72% |
| 2022-07-05 | Deerfield Management Company, L.P. | 9.64M | 9.40% |
| 2022-07-05 | James E. Flynn | 9.64M | 9.40% |
| 2022-07-05 | Deerfield Mgmt III, L.P. | 5.73M | 5.72% |
| 2022-07-05 | Deerfield Partners, L.P. | 3.9M | 4.90% |
| 2022-07-05 | Deerfield Mgmt, L.P. | 3.9M | 4.90% |
| 2022-04-27 | Deerfield Mgmt III, L.P. | 3.84M | 5.74% |
| 2022-04-27 | Deerfield Private Design Fund III, L.P. | 3.84M | 5.74% |
| 2022-04-27 | Deerfield Management Company, L.P. | 5.86M | 9.40% |
| 2022-04-27 | Deerfield Mgmt, L.P. | 2.01M | 4.90% |
| 2022-04-27 | Deerfield Partners, L.P. | 2.01M | 4.90% |
| 2022-04-27 | James E. Flynn | 5.86M | 9.40% |
| 2022-02-11 | Kerrisdale Advisers, LLC | - | 0.00% |
| 2022-02-11 | Kerrisdale Partners Master Fund, Ltd. | - | 0.00% |
| 2022-02-14 | Advent Life Sciences LLP | 1.62M | 5.80% |
| 2022-02-11 | 95-1411037 | 13.0 | 5.70% |
| 2022-02-11 | 95-1411037 | 13.0 | 5.70% |
| 2022-02-11 | Kerrisdale Partners Master Fund, Ltd. | - | 0.00% |
| 2022-02-11 | Sahm Adrangi | - | 0.00% |
| 2022-02-11 | Kerrisdale Advisers, LLC | - | 0.00% |
| 2022-02-11 | Sahm Adrangi | - | 0.00% |
| 2022-02-14 | Advent Life Sciences Fund I LP | 1.62M | 5.80% |
| 2022-02-14 | Shahzad Malik | 1.62M | 5.80% |
| 2021-08-26 | Deerfield Mgmt, L.P. | 2.01M | 4.90% |
| 2021-08-26 | Deerfield Mgmt III, L.P. | 3.84M | 5.81% |
| 2021-08-26 | Deerfield Private Design Fund III, L.P. | 3.84M | 5.81% |
| 2021-08-26 | Deerfield Management Company, L.P. | 5.85M | 9.50% |
| 2021-08-26 | Deerfield Partners, L.P. | 2.01M | 4.90% |
| 2021-08-26 | James E. Flynn | 5.85M | 9.50% |
| 2021-07-21 | Sahm Adrangi | 1.75M | 5.20% |
| 2021-07-21 | Kerrisdale Partners Master Fund, Ltd. | 1.75M | 5.20% |
| 2021-07-21 | Deerfield Private Design Fund III, L.P. | 3.84M | 11.29% |
| 2021-07-21 | Deerfield Mgmt, L.P. | 2.01M | 5.96% |
| 2021-07-21 | Deerfield Partners, L.P. | 2.01M | 5.96% |
| 2021-07-21 | Deerfield Management Company, L.P. | 5.85M | 17.19% |
| 2021-07-21 | James E. Flynn | 5.85M | 17.19% |
| 2021-07-21 | Kerrisdale Advisers, LLC | 1.75M | 5.20% |
| 2021-07-21 | Kerrisdale Advisers, LLC | 1.75M | 5.20% |
| 2021-07-21 | Deerfield Mgmt III, L.P. | 3.84M | 11.29% |
| 2021-07-21 | Sahm Adrangi | 1.75M | 5.20% |
| 2021-07-21 | Kerrisdale Partners Master Fund, Ltd. | 1.75M | 5.20% |
| 2021-02-11 | Fares Zahir | 1.17M | 4.20% |
| 2021-02-11 | Pulau Manukan Ventures Labuan Ltd. | 1.17M | 4.20% |
| 2021-02-11 | Pulau Manukan Ventures Labuan Ltd. | 1.17M | 4.20% |
| 2021-02-11 | AMXeraya Ltd | 1.17M | 4.20% |
| 2021-02-11 | AMXeraya Ltd | 1.17M | 4.20% |
| 2021-02-11 | Fares Zahir | 1.17M | 4.20% |
| 2021-02-10 | Shahzad Malik | 1.62M | 5.80% |
| 2021-02-10 | Advent Life Sciences Fund I LP | 1.62M | 5.80% |
| 2021-02-10 | Advent Life Sciences LLP | 1.62M | 5.80% |
| 2021-02-10 | Shahzad Malik | 1.62M | 5.80% |
| 2021-02-10 | Advent Life Sciences Fund I LP | 1.62M | 5.80% |
| 2021-02-10 | Advent Life Sciences LLP | 1.62M | 5.80% |
| 2020-08-20 | James E. Flynn | 4.78M | 17.14% |
| 2020-08-20 | Deerfield Private Design Fund III, L.P. | 3.16M | 11.36% |
| 2020-08-20 | Deerfield Mgmt, L.P. | 1.61M | 5.88% |
| 2020-08-20 | Deerfield Partners, L.P. | 1.61M | 5.88% |
| 2020-08-20 | Deerfield Mgmt III, L.P. | 3.16M | 11.36% |
| 2020-08-20 | Deerfield Private Design Fund III, L.P. | 3.16M | 11.36% |
| 2020-08-20 | Deerfield Management Company, L.P. | 4.78M | 17.14% |
| 2020-08-20 | Deerfield Management Company, L.P. | 4.78M | 17.14% |
| 2020-08-20 | James E. Flynn | 4.78M | 17.14% |
| 2020-08-20 | Deerfield Mgmt III, L.P. | 3.16M | 11.36% |
| 2020-08-20 | Deerfield Partners, L.P. | 1.61M | 5.88% |
| 2020-08-20 | Deerfield Mgmt, L.P. | 1.61M | 5.88% |
| 2020-08-18 | OrbiMed ROF II LLC | 1.59M | 5.80% |
| 2020-08-18 | OrbiMed ROF II LLC | 1.59M | 5.80% |
| 2020-08-18 | OrbiMed Capital GP IV LLC | 4.22M | 15.30% |
| 2020-08-18 | OrbiMed Advisors LLC | 5.81M | 20.90% |
| 2020-08-18 | OrbiMed Capital GP IV LLC | 4.22M | 15.30% |
| 2020-08-18 | OrbiMed Advisors LLC | 5.81M | 20.90% |
AFIB Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.06 | 29.77M | $1.64M | $14.02M | $35.76M | $23.38M |
| 2023-12-31 | $0.20 | 29.1M | $5.87M | $19.17M | $38.48M | $25.18M |
| 2022-12-31 | $1.15 | 28.47M | $32.74M | $25.58M | $38.86M | $46.01M |
| 2021-12-31 | $3.41 | 28.65M | $97.71M | $24.07M | $45.4M | $119.04M |
| 2020-12-31 | $28.81 | 11.41M | $328.65M | $25.23M | $41.08M | $344.5M |
| 2019-12-31 | $26.50 | 27.43M | $726.92M | $9.45M | $41.13M | $758.6M |
| 2018-12-31 | $26.50 | 16.85M | $446.57M | $9.62M | $25.86M | $462.81M |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2024-12-31 | $0.06 | 29.77M | $1.64M | $14.02M | $35.76M | $23.38M |
| 2024-09-30 | $0.08 | 29.8M | $2.5M | $12.6M | $35.78M | $25.69M |
| 2024-06-30 | $0.03 | 29.72M | $965.65K | $13.33M | $35.84M | $23.48M |
| 2024-03-31 | $0.18 | 29.69M | $5.34M | $18.46M | $38.47M | $25.35M |
| 2023-12-31 | $0.20 | 29.26M | $5.91M | $19.17M | $38.48M | $25.22M |
| 2023-09-30 | $0.70 | 29.26M | $20.38M | $24.1M | $38.93M | $35.21M |
| 2023-06-30 | $0.89 | 29.04M | $25.79M | $23.06M | $38.78M | $41.51M |
| 2023-03-31 | $0.75 | 28.76M | $21.69M | $22.74M | $38.75M | $37.7M |
| 2022-12-31 | $1.15 | 28.47M | $32.74M | $25.58M | $38.86M | $46.01M |
| 2022-09-30 | $0.88 | 28.36M | $24.96M | $28M | $38.91M | $35.86M |
| 2022-06-30 | $1.12 | 28.34M | $31.74M | $46.57M | $38.98M | $24.16M |
| 2022-03-31 | $1.39 | 28.12M | $39.08M | $12.32M | $45.76M | $72.53M |